Browse: Companies | People | Financial Organizations
Home > Companies > Zosano Pharma

General Information

Websitezosanopharma.com
CategoryBioTech
Phone510-745-1200
Employees
Founded10/06
DescriptionOsteoporosis Treatment Research

Offices

Fremont, USA
34790 Ardentech Court
Fremont, CA, 94555
USA

Funding

Tags

Zosano Pharma

Zosano Pharma is a private pharmaceutical company founded in October 2006 and is focused on creating better products with their innovative drug delivery technology.

Their lead program, parathyroid hormone (PTH) transdermal microprojection delivery system has finalized a Phase 2 clinical trial for treating severe osteoporosis. Zosano’s objective is to discover and develop therapeutic drug candidates which address large unmet medical needs or have a significant potential for commercialization.

Milestones

  • Received $30M in Series B funding. (8/6/09)
    Posted 8/6/09 at 10:23am
  • Received $90M in Series A funding. (11/15/07)
    Posted 7/14/09 at 3:46am

Videos

Screenshots

Zosano Pharma screenshot
Above: Zosano Pharma
Uploaded: 7/14/09

Sources

  1. Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million (zosanopharma.com) [edit]
  2. Zosano Pharma, Inc.: Series B $30M (onbiovc.com) [edit]
Edit This Page
Last Edited 9/24/09

Revision History RSS Picture

Recent Incoming Links

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy